The present study investigated the therapeutic potential of L-carnitine in mitigating inflammation and improving clinical outcomes in active RA patients, with a particular emphasis on the JAK/STAT signaling pathway and TGF-β1. The gene discussed is SOAT1; the disease is rheumatoid arthritis.